Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 6, 1999, Pages 1374-1381

  Bukusi, Elizabeth A ^b   Cohen, Craig R ^a   Stevens, Claire E ^b   Sinei, Samuel ^b   Reilly, Marie ^b   Grieco, Vereena ^b   Eschenbach, David A ^b   Holmes, King K ^b   Bwayo, Job ^b   Ndinya Achola, J O ^b   Kreiss, Joan ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Ambulatory antibiotic treatment; Bacterial vaginosis; Chlamydiosis; Disease; Gonorrhea; Human immunodeficiency virus 1; Pelvic inflammatory

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOMETRITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SERODIAGNOSIS; TREATMENT OUTCOME; VAGINITIS;

EID: 0038193040     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70378-9     Document Type: Article

References (24)

1. 1. Mathews T, Mati JK, Fomulu JN. A study of infertility in Kenya: results of investigation of the infertile couple in Nairobi. East Afr Med J 1981;58:288-97.
2. 2. Walton SM, Mati JK. An evaluation of secondary infertility in Kenya. East Afr Med J 1976;53:310-4.
3. 3. Ojwang AW, Lema VM, Wanjala SH. HIV infection among patients with acute pelvic inflammatory disease at the Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J 1993;70:506-11.
4. 4. Ratnam AV, Din SN, Chatterjee TK. Gonococcal infection in women with pelvic inflammatory disease in Lusaka, Zambia. Am J Obstet Gynecol 1980;138:965-8.
5. 5. Duncan ME, Tibaux G, Kloos H, Pelzer A, Mehari L, Perine PL, et al. STDs in women attending family planning clinics: a case study in Addis Ababa. Soc Sci Med 1997;44:441-54.
6. 6. Hoegsberg B, Abulafia O, Sedlis A, Feldman J, DesJalais D, Landesman S, et al. Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. Am J Obstet Gynecol 1990;163:1135-9.
7. 7. Korn AP, Landers DV, Green JR, Sweet RL. Pelvic inflammatory disease in human immunodeficiency virus infected women. Obstet Gynecol 1993;82:765-8.
8. 8. Barbosa C, Macasaet M, Brockmann S, Sierra MF, Xia Z, Duerr A. Pelvic inflammatory disease and human immunodeficiency virus infection. Obstet Gynecol 1997;89:65-70.
9. 9. Kamenga MC, De Cock KM, St Louis ME, Tour'e CK, Zakaria S, N'gbichi JM, et al. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case control study in Abidjan, Ivory Coast. Am J Obstet Gynecol 1995;172:919-25.
10. 10. Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:85-92.
11. 11. Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease: key treatment issues and options. JAMA 1991;266:2605-11.
12. 12. Anonymous. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1998;46:79-85.
13. 13. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, et al. HIV-I infection associated with abnormal vaginal flora morphology and bacterial vaginosis [published erratum appears in Lancet 1997;350:1036]. Lancet 1997;350;546-50.
14. 11. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995;9:1093-7.
15. 15. Wasserheit JN, Bell TA, Kiviat NB, Wølner-Hanssen P, Zabriskie V, Kirby BD, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104:187-93.
16. 16. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardised method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
17. 17. Stamm WE, Tam M, Koester M, Cles L. Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983;17:666-8.
18. 18. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease: a comprehensive analysis and considerations for developing a new model JAMA 1991;266:2594-604.
19. 19. Kiviat NB, Wølner-Hanssen P, Eschenbach DA, Wasserheit JN, Paavonen JA, Bell TA, et al. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990;14:167-75.
20. 20. World Health Organization Global Program on AIDS. Guidelines for the clinical management of HIV infection in adults. Geneva: The Organization; 1991. WHO/GPA/IDS/ HCS/91.6.
21. 21. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing new models. JAMA 1991;266:2594-604.
22. 22. Kimani J, Maclean TW, Bwayo JJ, MacDonald K, Oyugi J, Maitha GM, et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 1996;173:1437-44.
23. 23. Eschenbach DA, Buchanan TM, Pollock HM, Forsyth S, Alexander ER, Lin JS, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975;293:166-71.
24. 24. Cohen CR, Sinei S, Reilly M, Bukusi E, Eschenbach D, Holmes KK, et al. Effect of HIV 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis 1998;178:1352-8.